Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosomal membrane in tumor cells is a specialized phospholipid bilayer that encloses the lysosome, an organelle responsible for degradation and recycling of macromolecules. In cancer, the function and dynamics of lysosomes—and their membranes—are altered to support tumor growth, survival, invasion, and metastasis. It contains key proteins like LAMP1/LAMP2, V-ATPase, SNARE complexes, Cystinosin/Sialin involved in structural integrity, maintaining acidic environment, fusion events, and metabolite transport, respectively. The membrane plays a crucial role in metabolic adaptation, signaling, invasion, metastasis, and response to therapy, making it a potential therapeutic target.
Disruption or permeabilization of the lysosomal membrane leading to release of hydrolytic enzymes and induction of apoptosis or necrosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Cell Lysosomal Membrane.